Showing results (21-30 of 185) with videos related to

Sort By:
Pageof 19
JGH Open : an Open Access Journal of Gastroenterology and Hepatology|August 31, 2023
How do the 2022 European Society of Cardiology/European Respiratory Society guidelines modify the diagnosis of portopulmonary hypertension in patients with cirrhosis complicated by portal hypertension? A post hoc analysisMasanori Atsukawa, Akihito Tsubota, Yuichi Tamura, et al.
Journal of Gastroenterology and Hepatology|November 24, 2012
Lead-in treatment with interferon-β/ribavirin may modify the early hepatitis C virus dynamics in pegylated interferon alpha-2b/ribavirin combination for chronic hepatitis C patients with the IL28B minor genotypeNorio Itokawa, Masanori Atsukawa, Akihito Tsubota, et al.
ESC Heart Failure|March 15, 2022
Type III procollagen peptide level can indicate liver dysfunction associated with volume overload in acute heart failureAkihiro Shirakabe, Hirotake Okazaki, Masato Matsushita, et al.
Internal Medicine (Tokyo, Japan)|March 7, 2015
Safety and efficacy of partial splenic embolization in telaprevir-based triple therapy for chronic hepatitis CChisa Kondo, Masanori Atsukawa, Akihito Tsubota, et al.
BMC Gastroenterology|March 29, 2022
Prophylactic clip closure for mucosal defects is associated with reduced adverse events after colorectal endoscopic submucosal dissection: a propensity-score matching analysisJun Omori, Osamu Goto, Tsugumi Habu, et al.
Hepatology Research : the Official Journal of the Japan Society of Hepatology|January 15, 2014
Serum 25-hydroxyvitamin D3 levels affect treatment outcome in pegylated interferon/ribavirin combination therapy for compensated cirrhotic patients with hepatitis C virus genotype 1b and high viral loadMasanori Atsukawa, Akihito Tsubota, Noritomo Shimada, et al.
Hepatology Research : the Official Journal of the Japan Society of Hepatology|July 4, 2013
Predictive factors for improvement of ascites after transjugular intrahepatic portosystemic shunt in patients with refractory ascitesYasuhiko Taki, Hidenori Kanazawa, Yoshiyuki Narahara, et al.
World Journal of Gastroenterology|December 25, 2018
Relationship between response to lusutrombopag and splenic volumeHaruki Uojima, Yoshitaka Arase, Norio Itokawa, et al.
European Journal of Gastroenterology & Hepatology|April 16, 2014
Effect of fluvastatin on 24-week telaprevir-based combination therapy for hepatitis C virus genotype 1b-infected chronic hepatitis CMasanori Atsukawa, Akihito Tsubota, Noritomo Shimada, et al.
Hepatitis Monthly|January 10, 2014
Efficacy of Alfacalcidol on PEG-IFN/ Ribavirin Combination Therapy for Elderly Patients With Chronic Hepatitis C: A Pilot StudyMasanori Atsukawa, Akihito Tsubota, Noritomo Shimada, et al.
Pageof 19